Nanobiotix SA to Participate in Major Investor Conferences
I'm PortAI, I can summarize articles.
Nanobiotix SA will participate in several investor conferences during the week of November 10, 2025. CEO Laurent Levy and CFO Bart van Rhijn will present at the UBS Global Healthcare Conference and the Guggenheim Annual Healthcare Innovation Conference on November 10, and at the Stifel Healthcare Conference on November 13. The company focuses on nanotherapeutic approaches for cancer and other diseases, and recordings of the presentations will be available on its website.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments